Less than half of the surveyed US residents considered the vaccine against the coronavirus of the American company Johnson & Johnson to be relatively safe, on average one in five expressed readiness to be vaccinated with this drug. This is evidenced by the results of a poll published on April 26 by the ABC TV channel and The Washington Post.
According to the study, “public concerns about the Johnson & Johnson vaccine are widespread,” the article states.
The drug is considered relatively safe by 46% of respondents, 41% – called it hazardous to health. Among those who have not yet been vaccinated, only 22% expressed their readiness to be vaccinated with the drug of this company, 73% – on the contrary, did not want to be vaccinated with the J&J vaccine.
The poll in the United States was conducted even before experts from the federal Centers for Disease Control and Prevention (CDC) voted on April 24 to reactivate the vaccine, despite the fact that on April 13, experts from the CDC and the Food and Drug Administration of the Department of Health and Human Services US Services recommended that J&J be suspended due to possible side effects after using this drug.
Earlier, on April 9, in the United States, three Jonson & Jonson coronavirus vaccination centers located in North Carolina were temporarily closed due to the identification of side effects in 26 people after using the vaccine.
After using the drug, four people were admitted to hospitals for further examination. The US Centers for Disease Control and Prevention has described fainting as not uncommon after vaccination.
In total, 6.8 million people were vaccinated with the drug in the United States. At the same time, 15 cases of blood clots were registered in women aged 18 to 48 years 6-13 days after vaccination, three patients died.
According to Johns Hopkins University, during the coronavirus pandemic in the United States, more than 32 million cases of coronavirus infection were detected, 572,200 people died. In terms of the incidence and number of deaths due to COVID-19, the United States ranks first in the world.